Aurora-A Phosphorylates, Activates, and Relocalizes the Small GTPase RalA
Open accessThe DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Abstract
The small GTPase Ras, which transmits extracellular signals to the cell, and the kinase Aurora-A, which promotes proper mitosis, can both be inappropriately activated in human tumors. Here, we show that Aurora-A in conjunction with oncogenic Ras enhances transformed cell growth. Furthermore, such transformation and in some cases also tumorigenesis depend upon S194 of RalA, a known Aurora-A phosphorylation site. Aurora-A promotes not only RalA activation but also translocation from the plasma membrane and activation of the effector protein RalBP1. Taken together, these data suggest that Aurora-A may converge upon oncogenic Ras signaling through RalA.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“On the other hand, AURKA, in turn, promotes resistance to therapeutic targeting of EGFR and RAS pathway components by activating RAS downstream effectors such as RalA, ERK1/2, and AKT [132–134].”
From Differential Response and Resistance to KRAS-Targeted Therapy (2025) · cites this paper as [133]
Citations
Cites
ras oncogenes in human cancer: a review.
Bos, J. L. (1989) · PubMed · Cited by 5,061
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
Targeting RAS signalling pathways in cancer therapy
Downward, J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc969 · Cited by 3,256
Creation of human tumour cells with defined genetic elements
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345
Self-citationRAS oncogenes: the first 30 years
Malumbres, M., & Barbacid, M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1097 · Cited by 1,902 · cited 1×
“One-third of human cancers harbor point mutations in Ras that render the protein in a constitutively active GTP-bound state, promoting a host of cancer cell phenotypes (40).”
BackgroundGenetics and biology of pancreatic ductal adenocarcinoma
Hezel, A. F., Kimmelman, A. C., Stanger, B. Z., Bardeesy, N., & DePinho, R. A. (2006) · Genes & Development · doi:10.1101/gad.1415606 · Cited by 1,577
A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers
Bischoff, J. R. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3052 · Cited by 1,216
Rodriguez-Viciana, P., Warne, P. H., Khwaja, A., Marte, B. M., Pappin, D., Das, P., Waterfield, M. D., Ridley, A., & Downward, J. (1997) · Cell · doi:10.1016/s0092-8674(00)80226-3 · Cited by 1,061
Aurora-A — A guardian of poles
Marumoto, T., Zhang, D., & Saya, H. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1526 · Cited by 697
Aurora-kinase inhibitors as anticancer agents
Keen, N., & Taylor, S. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1502 · Cited by 675
Meraldi, P. (2002) · The EMBO Journal · doi:10.1093/emboj/21.4.483 · Cited by 658
Multiple ras functions can contribute to mammalian cell transformation
White, M. A., Nicolette, C., Minden, A., Polverino, A., Aelst, L. V., Karin, M., & Wigler, M. H. (1995) · Cell · doi:10.1016/0092-8674(95)90507-3 · Cited by 649
Anand, S., Penrhyn-Lowe, S., & Venkitaraman, A. R. (2003) · Cancer Cell · doi:10.1016/s1535-6108(02)00235-0 · Cited by 631
Bivona, T. G., Quatela, S. E., Bodemann, B. O., Ahearn, I. M., Soskis, M. J., Mor, A., Miura, J., Wiener, H. H., Wright, L., Saba, S. G., et al. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.012 · Cited by 467
Self-citationDistinct requirements for Ras oncogenesis in human versus mouse cells
Hamad, N. M., Elconin, J. H., Karnoub, A. E., Bai, W., Rich, J. N., Abraham, R. T., Der, C. J., & Counter, C. M. (2002) · Genes & Development · doi:10.1101/gad.993902 · Cited by 431
Self-citationThe exocyst is a Ral effector complex
Moskalenko, S., Henry, D. O., Rosse, C., Mirey, G., Camonis, J. H., & White, M. A. (2002) · Nature Cell Biology · doi:10.1038/ncb728 · Cited by 423 · cited 1×
“and pcDNA3-mycSec5 were previously described (16, 25, 36, 45).”
MethodChoudhury, A., Dominguez, M., Puri, V., Sharma, D. K., Narita, K., Wheatley, C. L., Marks, D. L., & Pagano, R. E. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15420 · Cited by 407
The Aurora kinases: Role in cell transformation and tumorigenesis
Katayama, H., Brinkley, W. R., & Sen, S. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1023789416385 · Cited by 398
Identification of a Mouse p21Cdc42/Rac Activated Kinase
Bagrodia, S., Taylor, S. J., Creasy, C. L., Chernoff, J., & Cerione, R. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.39.22731 · Cited by 394
Choudhury, A., Dominguez, M., Puri, V., Sharma, D. K., Narita, K., Wheatley, C. L., Marks, D. L., & Pagano, R. E. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215420 · Cited by 380
Chien, Y., Kim, S., Bumeister, R., Loo, Y.-M., Kwon, S. W., Johnson, C. L., Balakireva, M. G., Romeo, Y., Kopelovich, L., Gale, M., et al. (2006) · Cell · doi:10.1016/j.cell.2006.08.034 · Cited by 368
Aurora-A Kinase Maintains the Fidelity of Early and Late Mitotic Events in HeLa Cells
Marumoto, T., Honda, S., Hara, T., Nitta, M., Hirota, T., Kohmura, E., & Saya, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306275200 · Cited by 362
Activation of RalA is critical for Ras-induced tumorigenesis of human cells
Lim, K.-H., Baines, A. T., Fiordalisi, J. J., Shipitsin, M., Feig, L. A., Cox, A. D., Der, C. J., & Counter, C. M. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.030 · Cited by 355 · cited 8×
“Whereas RalA is required for Ras-mediated anchorage-independent growth (36, 38), RalB can instead be critical to cell viability, at least in some contexts (14, 15), particularly when cells are grown in the absence of substrate or during metastasis (38).”
BackgroundMethodSelf-citationKhosravi-Far, R., White, M. A., Westwick, J. K., Solski, P. A., Chrzanowska-Wodnicka, M., Van Aelst, L., Wigler, M. H., & Der, C. J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.7.3923 · Cited by 343
Self-citationMalumbres, M., & Barbacid, M. (2007) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2006.12.008 · Cited by 338
Bridging Ral GTPase to Rho Pathways
Jullien-Flores, V., Dorseuil, O., Romero, F., Letourneur, F., Saragosti, S., Berger, R., Tavitian, A., Gacon, G., & Camonis, J. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.38.22473 · Cited by 338
Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer.
Li, D., Zhu, J., Firozi, P. F., Abbruzzese, J. L., Evans, D. B., Cleary, K. R., Friess, H., & Sen, S. (2003) · PubMed · Cited by 335
Cdc42 Regulates Anchorage-Independent Growth and Is Necessary for Ras Transformation
Qiu, R.-G., Abo, A., McCormick, F., & Symons, M. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.6.3449 · Cited by 311
Cantor, S. B., Urano, T., & Feig, L. A. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.8.4578 · Cited by 310
Renewing the conspiracy theory debate: does Raf function alone to mediate Ras oncogenesis?
Repasky, G. A., Chenette, E. J., & Der, C. J. (2004) · Trends in Cell Biology · doi:10.1016/j.tcb.2004.09.014 · Cited by 300
Self-citationAurora kinases, aneuploidy and cancer, a coincidence or a real link?
Giet, R., Petretti, C., & Prigent, C. (2005) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.03.004 · Cited by 262
Wang, X., Zhou, Y.-X., Qiao, W., Tominaga, Y., Ouchi, M., Ouchi, T., & Deng, C.-X. (2006) · Oncogene · doi:10.1038/sj.onc.1209707 · Cited by 261
Divergent Roles for RalA and RalB in Malignant Growth of Human Pancreatic Carcinoma Cells
Lim, K.-H., O'Hayer, K., Adam, S. J., Kendall, S. D., Campbell, P. M., Der, C. J., & Counter, C. M. (2006) · Current Biology · doi:10.1016/j.cub.2006.10.023 · Cited by 250
Self-citationRal-GTPases: approaching their 15 minutes of fame.
Feig, L. A. (2003) · Trends in Cell Biology · doi:10.1016/s0962-8924(03)00152-1 · Cited by 249
Cifone, M. A., & Fidler, I. J. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.2.1039 · Cited by 243
Hata, T., Furukawa, T., Sunamura, M., Egawa, S., Motoi, F., Ohmura, N., Marumoto, T., Saya, H., & Horii, A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3981 · Cited by 217
The Tumor Suppressor PP2A Aβ Regulates the RalA GTPase
Sablina, A. A., Chen, W., Arroyo, J. D., Corral, L., Hector, M., Bulmer, S. E., DeCaprio, J. A., & Hahn, W. C. (2007) · Cell · doi:10.1016/j.cell.2007.03.047 · Cited by 203
RAL GTPases are linchpin modulators of human tumour‐cell proliferation and survival
Chien, Y., & White, M. A. (2003) · EMBO reports · doi:10.1038/sj.embor.embor899 · Cited by 193
Jullien-Flores, V., Mahé, Y., Mirey, G., Leprince, C., Meunier-Bisceuil, B., Sorkin, A., & Camonis, J. H. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.16.2837 · Cited by 186
(1995) · PubMed · Cited by 178
Stimulation of gene induction and cell growth by the Ras effector Rlf
Wolthuis, R. M. F. (1997) · The EMBO Journal · doi:10.1093/emboj/16.22.6748 · Cited by 163
Lim, K.-H., & Counter, C. M. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.10.014 · Cited by 159
Self-citationNovel function of human RLIP76: ATP-dependent transport of glutathione conjugates and doxorubicin
Awasthi, S., Cheng, J., Singhal, S. S., Saini, M. K., Pandya, U., Pikula, S., Bandorowicz-Pikula, J., Singh, S. V., Zimniak, P., & Awasthi, Y. C. (2000) · Biochemistry · doi:10.1021/bi992964c · Cited by 159
Zhang, D., Hirota, T., Marumoto, T., Shimizu, M., Kunitoku, N., Sasayama, T., Arima, Y., Feng, L., Suzuki, M., Takeya, M., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1208153 · Cited by 147
Shipitsin, M., & Feig, L. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.13.5746-5756.2004 · Cited by 147
Cawthon, R. M., O'Connell, P., Buchberg, A. M., Viskochil, D., Weiss, R. B., Culver, M., Stevens, J., Jenkins, N. A., Copeland, N. G., & White, R. (1990) · Genomics · doi:10.1016/0888-7543(90)90199-5 · Cited by 145
Activation of the Small GTPase Ral in Platelets
Wolthuis, R. M. F., Franke, B., van Triest, M., Bauer, B., Cool, R. H., Camonis, J. H., Akkerman, J.-W. N., & Bos, J. L. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.5.2486 · Cited by 142
Distinct roles of RalA and RalB in the progression of cytokinesis are supported by distinct RalGEFs
Cascone, I., Selimoglu, R., Ozdemir, C., Nery, E. D., Yeaman, C. A., White, M. A., & Camonis, J. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.166 · Cited by 140
Frequent gain of copy number on the long arm of chromosome 20 in human pancreatic adenocarcinoma
Fukushige, S., Waldman, F. M., Kimura, M., Abe, T., Furukawa, T., Sunamura, M., Kobari, M., & Horii, A. (1997) · Genes, Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199707)19:3<161::aid-gcc5>3.0.co;2-w · Cited by 122
Aurora-A Kinase Is Essential for Bipolar Spindle Formation and Early Development
Cowley, D. O., Rivera‐Pérez, J. A., Schliekelman, M. J., He, Y. J., Oliver, T. G., Lu, L., O'Quinn, R., Salmon, E. D., Magnuson, T., & Dyke, T. V. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01062-08 · Cited by 121
RalGDS-like factor (Rlf) is a novel Ras and Rap 1A-associating protein.
Wolthuis, R. M. F., BAUER, B. E., Veer, L. J. V., de Vries-Smits, A. M. M., Cool, R. H., Spaargaren, M., Wittinghofer, A., Burgering, B. M. T., & Bos, J. L. (1996) · PubMed · Cited by 120
Release of autoinhibition of ASEF by APC leads to CDC42 activation and tumor suppression
Mitin, N., Betts, L., Yohe, M. E., Der, C. J., Sondek, J., & Rossman, K. L. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1290 · Cited by 110
Self-citationRossé, C., L'Hoste, S., Offner, N., Picard, A., & Camonis, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302191200 · Cited by 106
Wu, J.-C., Chen, T.-Y., Yu, C.-T. R., Tsai, S.-J., Hsu, J.-M., Tang, M.-J., Chou, C.-K., Lin, W.-J., Yuan, C.-J., & Huang, C.-Y. F. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411068200 · Cited by 106
Tatsuka, M., Sato, S., Kitajima, S., Suto, S., Kawai, H., Miyauchi, M., Ogawa, I., Maeda, M., Ota, T., & Takata, T. (2004) · Oncogene · doi:10.1038/sj.onc.1208293 · Cited by 106
RalA-exocyst-dependent Recycling Endosome Trafficking Is Required for the Completion of Cytokinesis
Chen, X.-W., Inoue, M., Hsu, S. C., & Saltiel, A. R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512847200 · Cited by 100
RLIP76 is a major determinant of radiation sensitivity
Awasthi, S., Singhal, S. S., Yadav, S., Singhal, J., Drake, K., Nadkar, A., Zajac, E., Wickramarachchi, D., Rowe, N., Yacoub, A., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0968 · Cited by 88 · cited 1×
“The basis of this decreased transformation is unknown, but given that RalBP1 knockdown cells can be cultured extensively with no overt impact on passaging (not shown) and that mice homozygous for a gene trap mutation of RALBP1 (RIP1 and RLIP76) are viable (3), the decrease in anchorage-independent growth may be relate…”
BackgroundBozidis, P., Williamson, C. D., & Colberg‐Poley, A. M. (2007) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb0327s37 · Cited by 84
Expression of Ral GTPases, Their Effectors, and Activators in Human Bladder Cancer
Smith, S. C., Oxford, G., Baras, A. S., Owens, C., Havaleshko, D., Brautigan, D. L., Safo, M. K., & Theodorescu, D. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2419 · Cited by 82
A Genetically Defined Normal Human Somatic Cell System to Study Ras Oncogenesis In Vivo and In Vitro
O’Hayer, K., & Counter, C. M. (2006) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)07050-3 · Cited by 59
Self-citationBurum-Auensen, E., Angelis, P. M. D., Schjølberg, A. R., Kravik, K. L., Aure, M., & Clausen, O. P. F. (2007) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.6a7077.2007 · Cited by 59
Cytocentrin is a Ral-binding protein involved in the assembly and function of the mitotic apparatus
Quaroni, A., & Paul, E. C. A. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.5.707 · Cited by 52
Identification of Membrane-Anchoring Domains of RLIP76 Using Deletion Mutant Analyses
Yadav, S., Singhal, S. S., Singhal, J., Wickramarachchi, D., Knutson, E., Albrecht, T. B., Awasthi, Y. C., & Awasthi, S. (2004) · Biochemistry · doi:10.1021/bi0482811 · Cited by 47
Identification of Aurora Kinases as RasGAP Src Homology 3 Domain-binding Proteins
Gigoux, V., L'Hoste, S., Raynaud, F., Camonis, J., & Garbay, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200121200 · Cited by 42
Regenerative lesions in ulcerative colitis are characterized by microsatellite mutation
Heinen, C. D., Noffsinger, A. E., Belli, J., Straughen, J. E., Fischer, J. E., Groden, J. L., & Fenoglio‐Preiser, C. M. (1997) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199707)19:3<156::aid-gcc4>3.0.co;2-x · Cited by 36
MK615 inhibits pancreatic cancer cell growth by dual inhibition of Aurora A and B kinases
Okada, T., Sawada, T., Osawa, T., Adachi, M., & Kubota, K. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.1378 · Cited by 32
Functional Glucocorticoid Receptor Modulates Pancreatic Carcinoma Growth through an Autocrine Loop
Norman, J., Franz, M., Schiro, R., Nicosia, S. V., Docs, J., Fabri, P. J., & Gower, W. R. (1994) · Journal of Surgical Research · doi:10.1006/jsre.1994.1105 · Cited by 27
Genetically Engineered Human Cancer Models Utilizing Mammalian Transgene Expression
Kendall, S., Adam, S. J., & Counter, C. M. (2006) · Cell Cycle · doi:10.4161/cc.5.10.2734 · Cited by 25
Self-citationPamonsinlapatham, P., Hadj-Slimane, R., Raynaud, F., Bickle, M., Corneloup, C., Barthelaix, A., Lepelletier, Y., Mercier‐Gouy, P., Schapira, M., Samson, J., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002902 · Cited by 20
Warner, S. L., Muñoz, R. M., Bearss, D. J., Grippo, P. J., Han, H., & Hoff, D. D. V. (2008) · Pancreas · doi:10.1097/mpa.0b013e318176b9ae · Cited by 14
Research works printed but not linked: 4
- Bos J. L., 1989, Cancer Res, 49, 4682
- Li D., 2003, Clin. Cancer Res, 9, 991
- Park S. H., 1995, Oncogene, 11, 2349
- Wolthuis R. M., 1996, Oncogene, 13, 353
Cited by
Drugging the undruggable RAS: Mission Possible?
Cox, A. D., Fesik, S. W., Kimmelman, A. C., Luo, J., & Der, C. J. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4389 · Cited by 1,997
Self-citationRas superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?
Vigil, D., Cherfils, J., Rossman, K. L., & Der, C. J. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2960 · Cited by 819
Self-citationRas history: The saga continues
Cox, A. D., & Der, C. J. (2010) · Small GTPases · doi:10.4161/sgtp.1.1.12178 · Cited by 706
Self-citationTargeting protein prenylation for cancer therapy
Berndt, N., Hamilton, A. D., & Sebti, S. M. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3151 · Cited by 614
Rapid non-uniform adaptation to conformation-specific KRAS(G12C) inhibition
Xue, J. Y., Zhao, Y., Aronowitz, J., Mai, T. T., Vides, A., Qeriqi, B., Kim, D., Li, C., de Stanchina, E., Mazutis, L., et al. (2020) · Nature · doi:10.1038/s41586-019-1884-x · Cited by 543
Metadata
- Authors
- Lim, K.-H., Brady, D. C., Kashatus, D. F., Ancrile, B. B., Der, C. J., Cox, A. D., & Counter, C. M.
- Affiliations
- Duke University (US)
- Departments of Pharmacology
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Cox, Adrienne D.
- Counter, Christopher M.
- ORCID
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2010-01-01
- Volume
- 30
- Issue
- 2
- Pages
- 508-523
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC2798468
- OpenAlex
- W2100469448
- Cited by
- 126
- References
- 69
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 4 · 2023: 2 · 2022: 7 · 2021: 9 · 2020: 6 · 2019: 3 · 2018: 7 · 2017: 11 · 2016: 7 · 2015: 8 · 2014: 9 · 2013: 9 · 2012: 14
- FWCI
- 4.96
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- U.S. Department of Defense
- National Institutes of Health (5r01ca042978-30, NIH T32, CA67771, CA42978)
- National Cancer Institute (CA42978, R01CA109550, CA94184, CA 109550, CA 67771, R01-CA042978, R21CA126903, U19CA067771, CA126903, R01CA094184)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- AURKA, RalA, RALBP1, oncogenic Ras, small GTPase activation, cell transformation, carcinogenesis, mitosis, signal transduction, protein localization
- MeSH terms
- Animals, Humans, Mutation, Mice, SCID, Protein Serine-Threonine Kinases, ATP-Binding Cassette Transporters, ras Proteins, GTPase-Activating Proteins, ral GTP-Binding Proteins, Xenograft Model Antitumor Assays, Cell Line, Tumor, Mice, Aurora Kinase A, Aurora Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.